Clinical Trials Browser

NETWORK × Endometrial Adenocarcinoma × ALK1-Fc fusion protein, human × Clear all

NCT01642082 2018-03-13

Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

28 enrolled 9 charts

GenitourinaryGynecologic

Endometrial Adenocarcinoma